PUBLISHER: The Business Research Company | PRODUCT CODE: 1948611
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948611
Vascular imaging devices are medical tools that employ non-invasive techniques to visualize blood vessels and the circulatory system. They use various technologies to produce detailed images of the vascular network, assisting in the diagnosis and treatment of cardiovascular issues.
The primary categories of vascular imaging devices are minimally invasive and non-invasive. Minimally invasive procedures involve small incisions or catheters to access internal structures for diagnostic or therapeutic purposes. These devices are used in a range of applications, including diagnostics and treatment, serving end-users such as hospitals, diagnostic imaging centers, and other medical facilities.
Tariffs are impacting the vascular imaging devices market by increasing costs of imported sensors, imaging probes, semiconductor chips, high-resolution displays, and advanced computing components. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are elevating equipment acquisition costs and delaying technology upgrades. However, they are also promoting local assembly, regional manufacturing partnerships, and increased investment in domestic imaging technology capabilities.
The vascular imaging devices market research report is one of a series of new reports from The Business Research Company that provides vascular imaging devices market statistics, including vascular imaging devices industry global market size, regional shares, competitors with a vascular imaging devices market share, detailed vascular imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular imaging devices industry. This vascular imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vascular imaging devices market size has grown strongly in recent years. It will grow from $8.4 billion in 2025 to $8.89 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of diagnostic imaging infrastructure, adoption of ultrasound and angiography systems, increased use of hospital-based imaging services, availability of trained radiology professionals.
The vascular imaging devices market size is expected to see strong growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced imaging technologies, expansion of outpatient diagnostic centers, growing integration of imaging with digital health platforms, development of portable vascular imaging devices. Major trends in the forecast period include increasing integration of ai-based image analysis, rising adoption of non-invasive vascular imaging techniques, growing use of high-resolution imaging modalities, expansion of minimally invasive diagnostic procedures, enhanced focus on early cardiovascular diagnosis.
The rising prevalence of diabetes and hypertension is expected to drive the growth of the vascular imaging devices market going forward. Diabetes is a chronic metabolic disorder in which the body cannot produce or properly use insulin, while hypertension is characterized by persistently high arterial blood pressure that strains the vascular system. The increase in these conditions is fueled by aging populations, rising obesity rates, sedentary lifestyles, and unhealthy dietary habits. Vascular imaging supports clinical management by enabling early detection and continuous monitoring of vascular changes associated with diabetes and hypertension, facilitating timely evaluation of disease progression and treatment planning. For instance, in September 2025, according to the World Health Organization, a Switzerland-based international public health agency, 1.4 billion adults aged 30-79 worldwide had hypertension in 2024, with only 23% achieving controlled blood pressure. Therefore, the growing prevalence of diabetes and hypertension is driving the growth of the vascular imaging devices market.
Major companies operating in the vascular imaging devices market are focusing on developing next-generation intravascular ultrasound (IVUS) platforms enhanced with artificial intelligence to address the limitations of legacy systems. Next-generation IVUS platforms are sophisticated imaging tools that deliver high-resolution, real-time cross-sectional images of blood vessels, improving diagnostic accuracy, guiding interventions, and optimizing cardiovascular treatments. For instance, in October 2023, Evident Vascular Inc., a US-based med-tech company, emerged from stealth with $35 million in Series A financing to develop an advanced IVUS platform. This innovation surpasses older IVUS systems by offering superior image interpretation, streamlined workflow, and improved adoption in peripheral vascular procedures through AI-driven analysis. Supported by Vensana Capital, Evident Vascular's technology is initially targeted for peripheral arteries, with future applications planned for coronary interventions.
In September 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.28 billion. This acquisition enhances Boston Scientific's vascular portfolio, enabling the company to offer comprehensive solutions for physicians treating peripheral vascular diseases. Silk Road Medical's technology supports minimally invasive procedures, which can shorten recovery times and reduce complications compared to traditional open surgery methods. Silk Road Medical, a US-based medical device company, specializes in creating and manufacturing devices for treating carotid artery diseases, particularly through its innovative Transcarotid Artery Revascularization (TCAR) platform.
Major companies operating in the vascular imaging devices market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Bracco Group, Carestream Health Inc., Hitachi Medical Corporation, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Christie Medical Holdings Inc., Fujifilm Healthcare Corporation, Esaote SpA, Mindray Medical International Limited, Ziehm Imaging GmbH, Samsung Medison Co. Ltd., United Imaging Healthcare
North America was the largest region in the vascular imaging devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vascular imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vascular imaging devices market consists of sales of angiography systems, intravascular ultrasound systems, high-speed computed tomography systems, and portable doppler devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vascular Imaging Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vascular imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vascular imaging devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular imaging devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.